Product: 655-812 Prentox® Perm-X™ UL 31-66 Material Safety Data Sheet U.S. Department of Labor (OSHA 29 CFR 1910.1200) Manufacturer's Name: Prentiss Incorporated C. B. 2000 Floral Park, NY 11001 Telephone Number: (516) 326-1919 Section 1: Chemical Identification Product: 655-812 Prentox® Perm-X™ UL 31-66 EPA Signal Word: CAUTION Active Ingredients (%): Permethrin (31%) (CAS # 52645-53-1) Piperonyl Butoxide Technical (66%) (CAS #51-03-6) Chemical Class: Insecticide mixture Section 2: Composition/Information on Ingredients OSHA ACGIH NTP/IARC/OSHA Material: PEL TLV Other Carcinogen Permethrin N/A N/A Not Est. No Piperonyl Butoxide Technical Not Est. Not Est. Not Est. No Section 3: Hazards Identification Primary Routes of Entry: Eye and skin contact, inhalation. Prolonged or frequent repeated skin contact with permethrin may cause allergic reaction in some individuals. Repeated and prolonged skin contact with piperonyl butoxide may cause skin irritation. This product may cause temporary eye irritation. Symptoms of Acute Exposure Large, toxic doses of permethrin, administered to laboratory animals, have produced central nervous system effects with symptoms that include diarrhea, salivation, bloody nose, tremors and intermittent convulsions. Overexposure to permethrin via inhalation also produced hyperactivity and hypersensitivity. Section 4: First Aid Measures Ingestion: Immediately call a physician or Poison Control Center or doctor. Do not induce vomiting unless told by a poison control center or a doctor. Do not give any liquid to the person. Do not give anything by mouth to an unconscious person. Eye Contact: Immediately flush eyes with large amounts of water and continue flushing until irritation subsides. If irritation persists, seek medical attention (based on solvent). Skin Contact: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15 to 20 minutes. Call a Poison Control Center for treatment advice. Inhalation: The solvent in this product has a low vapor pressure and is not expected to present an inhalation exposure hazard during mixing and loading. Follow directions for use on product packaging when applying this product. Note to Physician: Contains petroleum distillate – vomiting may cause aspiration hazard. Product: 655-812 Prentox® Perm-X™ UL 31-66
Section 5: Fire Fighting Measures Fire and Explosion Flash Point (Test Method): 260O F (TCC) Flammable Limits (% in air): Lower: N/A Upper: N/A Unusual Fire, Explosion and Reactivity Hazards The solvent in this product may generate dense smoke when burning. Carbon monoxide, carbon dioxide and other oxides may be generated as products of combustion. In case of Fire Use water fog, dry chemical, foam or CO2 extinguishing media. Wear full protective clothing and self- contained breathing apparatus. Evacuate nonessential personnel from the area to prevent human exposure to fire, smoke, fumes or products of combustion. Prevent use of contaminated buildings, area and equipment until decontaminated. Use as little water as possible to prevent spread of contaminated runoff. Section 6: Accidental Release Measures Wear chemical safety glasses with side shields or chemical goggles, rubber gloves, rubber boots, long- sleeved shirt, long pants, to prevent contact with spilled material. For small spills, cover the spill with an absorbent material such as pet litter. Sweep up and place in an approved chemical container. Wash the spill area with water containing a strong detergent, absorb with pet litter or other absorbent material, sweep up and place in a chemical container. Seal the container and handle in an approved manner. Flush the area with water to remove any residue. Do not allow wash water to contaminate water supplies. Section 7: Handling and Storage Store the material in a well-ventilated, secure area, out of the reach of children and domestic animals. Do not store food, beverages or tobacco products in the storage area. Prevent eating, drinking, tobacco usage, and cosmetic application in areas where there is a potential for exposure to the material. Always wash thoroughly after handling. Section 8: Exposure Controls/Personal Protection Ingestion: Prevent eating, drinking, tobacco usage and cosmetic application in areas where there is a potential for exposure to the material. Always wash thoroughly after handling. Eye Contact: To avoid eye contact, wear safety glasses with side shields or chemical goggles. Skin Contact: To avoid skin contact, wear rubber gloves, rubber boots, long-sleeved shirt, and long pants. Inhalation: Avoid breathing vapors or mist. Section 9: Physical and Chemical Properties Appearance: Clear light amber liquid Odor: Slight solvent and licorice. Melting Point: N/A Boiling Point: N/D Specific Gravity/Density: 1.0797-1.0853 pH: N/A Product: 655-812 Prentox® Perm-X™ UL 31-66
Solubility in water: Oil solution, will not mix in water. Vapor Pressure: N/D % Volatile by volume: N/D Section 10: Stability and Reactivity Reactivity:
Stability Stable Hazardous Polymerization: Will not occur Conditions to avoid: Flame, heat, ignition sources and strong oxidizers or reducing
Hazardous Decomposition Products: Carbon monoxide and/or carbon dioxide. Chlorine and hydrogen chloride may be formed. Section 11: Toxicological Information Acute Toxicity/Irritation Studies Ingestion: Oral LD50 (Rat): >500 to <5,000 mg./Kg. (female) >5,000 mg./Kg. (male) Dermal: Dermal LD50 (Rat): >2,000 mg/Kg. Inhalation: 4-hour LC50 (Rat): >2.02 mg./L. Eye Contact: Minimally irritating Skin Contact: Non-irritating. Skin Sensitization: Permethrin is a skin sensitizer in some individuals. Mutagenic Potential: Permethrin and Piperonyl Butoxide did not produce any mutagenic Reproductive Hazard Potential: Permethrin and Piperonyl Butoxide were not teratogenic when Chronic/Subchronic Toxicity Studies: Carcinogenic Potential: Permethrin: A statistically significant increase of lung and liver tumors was
observed in female mice receiving diets containing 375 and 750 mg/Kg/day over 85 weeks. Piperonyl Butoxide: Marginally higher incidences of benign liver tumors in mice were observed following lifetime high dose exposures. The significance of this observation is questionable and under review. The doses at which tumors were observed greatly exceeded human dietary intake. At anticipated dietary exposure levels, it is highly unlikely that piperonyl butoxide would result in carcinogenic effects.
Section 12: Ecological Information Summary of Effects: Permethrin and piperonyl butoxide are highly toxic to fish and other aquatic organisms. Do not apply directly to water, or to areas where surface water is present or to intertidal areas below the mean high water mark other than as instructed on the product label. Do not contaminate water by disposing of equipment washwater. Apply this product only as specified on the label. Product: 655-812 Prentox® Perm-X™ UL 31-66 Section 13: Disposal Considerations Disposal: Do not reuse product containers. Dispose of product containers, waste containers, and residues according to Federal, State and local health and environmental regulations. Characteristic Waste: Ignitable Listed Waste: N/A Section 14: Transport Information DOT Classification: Pesticides, liquid, toxic, n.o.s. (permethrin), 6.1, UN2902, PG III B/L Freight Classification: Insecticides: other than poison, NMFC item 102120 International Transportation: Not Available Section 15: Regulatory Information SARA Title III Classification:
Section 311/312: Acute Health Hazard – Yes Chronic Health Hazard – Yes Fire Hazard – No Sudden release of pressure hazard – No Reactivity hazard – No Section 313 chemicals:
Permethrin (31%) (CAS # 52645-53-1) Piperonyl Butoxide (66%) (CAS # 51-03-6)
This product contains a toxic chemical or chemicals subject to the reporting requirements of Section 313 of Title III and of 40 CFR 372. Any copies or redistribution of this MSDS must include this notice. Proposition 65: Not applicable RCRA Classification: Ignitable TSCA Status: Exempt from TSCA Section 16: Other Information NFPA Hazard Ratings:
Health 1 0 Least Flammability 0 1 Slight Reactivity 0 2 Moderate
Date Prepared: September 9, 2002 Supersedes: N/A Reason: Initial Issue. ____________________________________________________________________________________ The information and recommendations contained herein are based upon data believed to be correct. However, no guarantee or warranty of any kind, expressed or implied, is made with respect to the information contained herein.
Backgrounder 3 Novolizer®: significant advance in inhalation therapy for improved asthma management Following a symposium at last year’s European Respiratory Society congress Professor Peter Barnes (Imperial College, London) concluded that “Inhaled therapy is likely to remain predominant in the future and the type of inhaler is just as important as the class of drug in the long-
the binding of the dye coated with cotinine conjugate to the antibodies on References the membrane. This prevents the formation of a line on the membrane. 1. U.S. Department of Health and Human Services, Public Health Service,Therefore, a cotinine-positive urine sample will not generate a line at theCenters for Disease Control: Reducing the Health Consequences of Smoking, 25 Years of Pr